Cipla has launched a new RT-PCR test kit ViraGen in India.The company announced that the new test kit for COVID-19 will be commercialised in the country in partnership with Ubio Biotechnology Systems.
ViraGen is a real-time detection kit approved by the Indian Council of Medical Research and is based on multiplex PCR technology. It helps to identify and detect SARS- CoV-2 N Gene and ORF lab gene with the sensitivity of 98.6% and the specificity of 98.8% as compared to a standard ICMR test.
This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19.
ViraGen is Cipla’s third offering in the COVID-19 testing segment. The company will commence supply of the virus detection kit from May 25, 2021.Cipla already has partnerships for antibody detection kits and antigen test kits.